About inHEART
inHEART is committed to delivering the world’s most sophisticated, AI-enabled, digital twin of the heart to advance the care of patients living with cardiac disease. We believe all patients deserve access to world-class expertise that guides and optimizes treatment strategies to support improved clinical outcomes and return patients to full, healthy lives.
Advertisement
Here you will find inHEART
Last viewed contents
BionFarming GmbH - Hennigsdorf, Germany
Accelero Biostructures - San Francisco, USA
Ori Biotech Ltd - London, United Kingdom
Biograil ApS - Hedehusene, Denmark
Restriction of hazardous substances in tattoo inks
IBR Inc. - Matzingen, Switzerland
Innerspace GmbH - Innsbruck, Austria
First synthesis of open-chain N-stereogenic amines achieved - Study enables enantiomerically pure products for drug development.
Being fit Protects Against Health Risks Caused by Stress at Work
QIAGEN to acquire Parse Biosciences - Entering the age of single-cell AI
Diagnosia Internetservices GmbH - Wien, Austria
